BCAL Diagnostics Limited (AU:BDX)
ASX:BDX
Australian Market
Holding AU:BDX?
Track your performance easily

BCAL Diagnostics Limited (BDX) Income Statement

6 Followers

BCAL Diagnostics Limited Income Statement

Last quarter (Q4 2022), BCAL Diagnostics Limited's total revenue was AU$―. In Q4, BCAL Diagnostics Limited's net income was AU$―. See BCAL Diagnostics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 22
Total Revenue
-
Cost of Revenue
-
Gross Profit
-
Operating Expense
AU$ 4.10M
Operating Income
AU$ -4.10M
Net Non Operating Interest Income Expense
AU$ 18.64K
Other Income Expense
AU$ 700.03K
Pretax Income
AU$ -3.39M
Tax Provision
AU$ 0.00
Earnings From Equity Interest Net Of Tax
-
Net Income Common Stockholders
AU$ -3.39M
Basic EPS
AU$ -0.02
Diluted EPS
AU$ -0.02
Basic Average Shares
AU$ 204.29M
Diluted Average Shares
AU$ 204.29M
Dividend Per Share
-
Total Operating Income As Reported
-
Reported Normalized Basic E P S
-
Reported Normalized Diluted E P S
-
Rent Expense Supplemental
-
Total Expenses
-
Net Income From Continuing And Discontinued Operation
AU$ -3.39M
Normalized Income
AU$ -3.39M
Interest Expense
-
EBIT
AU$ -4.10M
EBITDA
AU$ -4.08M
Currency in AUD

BCAL Diagnostics Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis